- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02006940
The Study Of Probe-Based Confocal Laser Endomicroscopy Of Distal Airways In Diagnostics Of Lung Diseases (pCLE)
December 5, 2013 updated by: Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
Comparative Study Of The Methods Of Probe-Based Confocal Laser Endomicroscopy Of Distal Airways, High Resolution Computed Tomography And Morphology In Diagnostics Of Lung Diseases
The study is devoted to the comparative analysis of the data received in patients with lung pathology using new method of probe-based confocal laser endoscopy of distal airways and two reference methods: high resolution computed tomography and morphology.
Study Overview
Status
Unknown
Intervention / Treatment
Detailed Description
A relatively new technology in pulmonary medicine, probe-based confocal laser endomicroscopy of distal airways, which is also called alveoscopy, allows for real-time minimally invasive intraacinar imaging.
This method has been developed that special miniprobe can be passed into the distal airway via the working channel of the bronchoscope and provide so called "optical biopsy".
The method is based on the natural autofluorescence of pulmonary structures, detecting the elastin scaffold of central and peripheral airways, the structure of alveoli, blood vessels and alveolar macrophages.
Taking into account the fact that in vivo endomicroscopy of distal airways is a novel diagnostic technique it needs correlating the obtained data at certain disease with the reference methods for the challenges of our current understanding of interpreting endomicroscopic images.
We choose high resolution computed tomography and morphology as such reference methods.
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Moscow, Russian Federation, 115682
- Recruiting
- Federal Research Clinical Center FMBA Russia
-
Sub-Investigator:
- Alexander V. Averyanov, MD, PhD
-
Sub-Investigator:
- Anastasia V. Sorokina, MD
-
Sub-Investigator:
- Dmitry V. Sazonov, MD
-
Sub-Investigator:
- Viktor N. Zabozlaev, MD
-
Sub-Investigator:
- Anna G. Sotnikova, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient Informed Consent;
- patients' fitness;
- the diagnosis of one of the following lung diseases: COPD, pneumonia, solitary nodule, pulmonary sarcoidosis, idiopathic interstitial pneumonia, hypersensitivity pneumonitis, pulmonary vasculitis, pulmonary eosinophilia, hemochromatosis, histiocytosis X, pulmonary lymphangioleiomyomatosis; alveolar proteinosis, other rare lung disease
- high resolution computed tomography scans performed not later than one month before pCLE;
- planned or performed histology
Exclusion Criteria:
- Severe respiratory failure,
- pregnancy or breast feeding,
- lung bleeding,
- any acute or chronic disease that may be a contraindication to bronchoscopy,
- any significant blood coagulation disorder,
- any diseases of hematopoietic system,
- alcoholism or toxic addiction,
- taking part in other clinical trials,
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Alveoflex, in vivo imaging miniprobe
All the patients will be examined using confocal laser endomicroscopy during bronchoscopy with a special minirobe Alveoflex before and after the treatment.
Records will be done and analyzed prospectively with the included software for endomicroscopic system.
|
Alveoflex uses 488nm laser, generating real time moving images with an optical area of 600μm at a video frame rate of 12 images per second and a focus depth of 50μm
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants with the Correspondence of pCLE Images to HRCT and Morphologic Data as a Measure of Specificity and Sensitivity of the Method
Time Frame: up to three years
|
pCLE images will be assessed morphometrically.
Such criteria as quantity of alveolar macrophages, quantity of floating intraalveolar substances etc. will be measured using 6-point score, where zero means the absence of the symptom and 5 - the maximal expressiveness.
Thickness of interalveolar septum, diameter of microvessels and thickness of elastic fibers will be measured using special tool with the included software for endomicroscopic system.
Radiologic signs e.g.
low-density areas and consolidation areas will be assessed in Hounsfield Units.
Other radiologic signs e.g.
ground-glass opacity, crazy paving patterns etc. will be measured by 6-point scale, the same as for pCLE images.
Morphological analysis of the lung tissue specimens (received as a result of transbronchial biopsy) will be made according to the structures in pCLE images for 20 fields of view.
|
up to three years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of Participants with Adverse Events as a Measure of Safety and Tolerability
Time Frame: up to two years
|
up to two years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Olesya Danilevskaya, MD, Federal Research Clinical Center FMBA Russia
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2011
Primary Completion (Anticipated)
December 1, 2015
Study Completion (Anticipated)
September 1, 2016
Study Registration Dates
First Submitted
November 28, 2013
First Submitted That Met QC Criteria
December 5, 2013
First Posted (Estimate)
December 10, 2013
Study Record Updates
Last Update Posted (Estimate)
December 10, 2013
Last Update Submitted That Met QC Criteria
December 5, 2013
Last Verified
December 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FRCC FMBA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammatory, Interstitial, Rare Lung Diseases
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruitingIdiopathic Inflammatory Myopathy | Interstitial Lung DiseaseChina
-
McGill University Health Centre/Research Institute...RecruitingInterstitial Lung Disease | Myopathy, InflammatoryCanada
-
Matthias GrieseSuspendedInterstitial Lung Disease | Diffuse Parenchymal Lung Disease | Children´s Interstitial Lung DiseaseGermany
-
Children's Hospital of Fudan UniversityNot yet recruitingInterstitial Lung Disease | Surfactant DysfunctionChina
-
Shanghai Pulmonary Hospital, Shanghai, ChinaUnknownInterstitial Lung DiseasesChina
-
Institut National de la Santé Et de la Recherche...RecruitingInterstitial Lung DiseasesFrance
-
Chonbuk National UniversityUnknownInterstitial Lung Diseases | Lung Cancer, | ER Stress, | Chronic Airway Disorders,Korea, Republic of
-
Andreas GuentherActive, not recruitingIdiopathic Pulmonary Fibrosis | Idiopathic Interstitial Pneumonia | Interstitial Lung Diseases | Diffuse Parenchymal Lung DiseasesUnited Kingdom, Germany, Austria, Italy, France
-
First Affiliated Hospital of Wenzhou Medical UniversityChia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Boehringer IngelheimNo longer availableLung Diseases, Interstitial (in Pediatric Populations) | Childhood Interstitial Lung Disease (chILD)
Clinical Trials on miniprobe Alveoflex
-
Federal Research Clinical Center of Federal Medical...UnknownCOVID-19Russian Federation
-
University Hospital, RouenCompletedPulmonary Nodule Persistent | Malignant Neoplasm of the Respiratory System | Benign Neoplasms of the Respiratory SystemFrance
-
Boston Children's HospitalWithdrawnDisorder Related to Lung TransplantationUnited States
-
Haukeland University HospitalHelse Sunnmore, 6026 ÅlesundCompleted
-
Singapore General HospitalCompletedDiffuse Parenchymal Lung DiseasesSingapore
-
University of California, IrvineCompleted
-
Midwest Biomedical Research FoundationAmerican Society for Gastrointestinal EndoscopyUnknownAdenomatous Polyps | Colon Cancer | Colon PolypsUnited States